Vicore Pharma Holding AB (VCRE)
VCRE Stock Price Chart
Explore Vicore Pharma Holding AB interactive price chart. Choose custom timeframes to analyze VCRE price movements and trends.
VCRE Company Profile
Discover essential business fundamentals and corporate details for Vicore Pharma Holding AB (VCRE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
2 Jul 2026
Employees
40.00
Website
https://vicorepharma.comCEO
Ahmed Mousa
Description
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
VCRE Financial Timeline
Browse a chronological timeline of Vicore Pharma Holding AB corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 Aug 2026
EPS estimate is -$0.05, while revenue estimate is $55.05k.
Earnings released on 6 May 2026
EPS came in at -$0.04 surpassing the estimated -$0.05 by +18.75%, while revenue for the quarter reached $63.23k , beating expectations by +26.00%.
VCRE Stock Performance
Access detailed VCRE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
